Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 09 2023
Historique:
medline: 23 8 2023
pubmed: 22 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

To know the prevalence of atrial fibrillation (AF), as well as the incidence of postoperative AF (POAF) in vascular surgery for arterial diseases and its outcome implications. We performed a systematic review and meta-analysis following the PRISMA statement. After the selection process, we analyzed 44 records (30 for the prevalence of AF history and 14 for the incidence of POAF).The prevalence of history of AF was 11.5% [95% confidence interval (CI) 1-13.3] with high heterogeneity (I2 = 100%). Prevalence was higher in the case of endovascular procedures. History of AF was associated with a worse outcome in terms of in-hospital death [odds ratio (OR) 3.29; 95% CI 2.66-4.06; P < 0.0001; I2 94%] or stroke (OR 1.61; 95% CI 1.39-1.86; P < 0.0001; I2 91%).The pooled incidence of POAF was 3.6% (95% CI 2-6.4) with high heterogeneity (I2 = 100%). POAF risk was associated with older age (mean difference 4.67 years, 95% CI 2.38-6.96; P = 0.00007). The risk of POAF was lower in patients treated with endovascular procedures as compared with an open surgical procedure (OR 0.35; 95% CI 0.13-0.91; P = 0.03; I2 = 61%). In the setting of vascular surgery for arterial diseases a history of AF is found overall in 11.5% of patients, more frequently in the case of endovascular procedures, and is associated with worse outcomes in terms of short-term mortality and stroke.The incidence of POAF is overall 3.6%, and is lower in patients treated with an endovascular procedure as compared with open surgery procedures. The need for oral anticoagulants for preventing AF-related stroke should be evaluated with randomized clinical trials.

Identifiants

pubmed: 37605953
doi: 10.2459/JCM.0000000000001533
pii: 01244665-202309000-00004
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

612-624

Informations de copyright

Copyright © 2023 Italian Federation of Cardiology - I.F.C. All rights reserved.

Références

Maisano A, Vitolo M, Imberti JF, et al. Atrial fibrillation in the setting of acute pneumonia: not a secondary arrhythmia. Rev Cardiovasc Med 2022; 23:176.
Vitolo M, Bonini N, Imberti JF, Boriani G. Atrial fibrillation in pneumonia: what clinical implications at long-term? Intern Emerg Med 2022; 23:1–4.
Dobrev D, Aguilar M, Heijman J, Guichard J-B, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019; 16:417–436.
Albini A, Malavasi VL, Vitolo M, et al. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: a systematic review and metanalysis. Eur J Intern Med 2021; 85:27–33.
Goyal P, Kim M, Krishnan U, et al. others. Postoperative atrial fibrillation and risk of heart failure hospitalization. Eur Heart J 2022; 43:2971–2980.
Gialdini G, Nearing K, Bhave PD, et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 2014; 312:616–622.
Caldonazo T, Kirov H, Rahouma M, et al. Atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2023; 165:94–103. e24.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C. others. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42:373–498.
Marazzato J, Masnaghetti S, De Ponti R, et al. Long-term survival in patients with post operative atrial fibrillation after cardiac surgery: analysis from a prospective cohort study. J Cardiovasc Dev Dis 2021; 8:169.
Nomani H, Mohammadpour AH, Reiner Ž, Jamialahmadi T, Sahebkar A. Statin therapy in post-operative atrial fibrillation: focus on the anti-inflammatory effects. J Cardiovasc Dev Dis 2021; 8:24.
Shvartz V, Le T, Kryukov Y, et al. Colchicine for prevention of atrial fibrillation after cardiac surgery in the early postoperative period. J Clin Med 2022; 11:1387.
Musa AF, Dillon J, Md Taib ME, et al. Incidence and outcomes of postoperative atrial fibrillation after coronary artery bypass grafting of a randomized controlled trial: a blinded end-of-cycle analysis. Rev Cardiovasc Med 2022; 23:122.
Shvartz V, Le T, Enginoev S, et al. Colchicine in cardiac surgery: the COCS randomized clinical trial. J Cardiovasc Dev Dis 2022; 9:363.
Wang X, Peng X, Li Y, et al. Colchicine for prevention of post-cardiac surgery and post-pulmonary vein isolation atrial fibrillation: a meta-analysis. Rev Cardiovasc Med 2022; 23:387.
Rostagno C, Cartei A, Rubbieri G, et al. Postoperative atrial fibrillation is related to a worse outcome in patients undergoing surgery for hip fracture. Intern Emerg Med 2021; 16:333–338.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372:n71.
Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating nonrandomised intervention studies. Health Technol Assessm 2003; 7:iii–173.
R Core Team. R: a language and environment for statistical computing . Vienna, Austria: R Foundation for Statistical Computing; 2021.
R Studio Team. RStudio: Integrated development environment for r . Boston, MA: RStudio, PBC; 2020.
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid-Based Ment Health 2019; 22:153–160.
Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36:1–48.
Tu JV, Wang H, Bowyer B, Green L, Fang J, Kucey D. Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario carotid endarterectomy registry. Stroke 2003; 34:2568–2573.
Diepen S van, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation 2011; 124:289–296.
Sanders RD, Bottle A, Jameson SS, et al. Independent preoperative predictors of outcomes in orthopedic and vascular surgery: the influence of time interval between an acute coronary syndrome or stroke and the operation. Ann Surg 2012; 255:901–907.
Harthun NL, Stukenborg GJ. Atrial fibrillation is associated with increased risk of perioperative stroke and death from carotid endarterectomy. J Vasc Surg 2010; 51:330–336.
Mao C-T, Tsai M-L, Wang C-Y, et al. Outcomes and characteristics of patients undergoing percutaneous angioplasty followed by below-knee or above-knee amputation for peripheral artery disease. PLoS One 2014; 9:e111130.
Qureshi AI, Chaudhry SA, Qureshi MH, Suri MFK. Rates and predictors of 5-year survival in a national cohort of asymptomatic elderly patients undergoing carotid revascularization. Neurosurgery 2015; 76:34–40.
Sevilla N, Clara A, Diaz-Duran C, Ruiz-Carmona C, Ibañez S. Survival after endovascular abdominal aortic aneurysm repair in a population with a low incidence of coronary artery disease. World J Surg 2016; 40:1272–1278.
Siddiq F, Adil MM, Malik AA, Qureshi MH, Qureshi AI. Effect of carotid revascularization endarterectomy versus stenting trial results on the performance of carotid artery stent placement and carotid endarterectomy in the United States. Neurosurgery 2015; 77:726–732. discussion 732.
Watanabe M, Chaudhry SA, Adil MM, et al. The effect of atrial fibrillation on outcomes in patients undergoing carotid endarterectomy or stent placement in general practice. J Vasc Surg 2015; 61:927–932.
Huang H-L, Jimmy Juang J-M, Chou H-H, et al. Immediate results and long-term cardiovascular outcomes of endovascular therapy in octogenarians and nonoctogenarians with peripheral arterial diseases. Clin Interv Aging 2016; 11:535–543.
Atti V, Nalluri N, Kumar V, et al. Frequency of 30-day readmission and its causes after endovascular aneurysm intervention of abdominal aortic aneurysm (from the nationwide readmission database). Am J Cardiol 2019; 123:986–994.
Huang H-L, Tzeng I-S, Chou H-H, et al. Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease. J Formosan Med Assoc 2020; 119:1052–1060.
Mazzaccaro D, Modafferi A, Malacrida G, Nano G. Assessment of long-term survival and stroke after carotid endarterectomy and carotid stenting in patients older than 80 years. J Vasc Surg 2019; 70:522–529.
Moussa Pacha H, Al-Khadra Y, Darmoch F, et al. Comparison of in-hospital outcomes in patients having limb-revascularization with versus without atrial fibrillation. Am J Cardiol 2019; 124:1540–1548.
Reis PV, Lopes AI, Leite D, et al. Major cardiac events in patients admitted to intensive care after vascular noncardiac surgery: a retrospective cohort. Semin Cardiothorac Vasc Anesth 2019; 23:293–299.
D’cruz RT, Chong TT, Tan TF, et al. The modified frailty index does not predict mortality after major lower extremity amputation for peripheral arterial disease in an Asian population. Ann Vasc Surg 2020; 69:298–306.
González-Fajardo JA, Ansuategui M, Romero C, Comanges A, Cases C, Gómez-Arbeláez D. Atrial fibrillation and surgical patients with peripheral arterial disease. Ann Vasc Surg 2020; 67:411–416.
Nejim B, Mathlouthi A, Weaver L, Faateh M, Arhuidese I, Malas MB. Safety of carotid artery revascularization procedures in patients with atrial fibrillation. J Vasc Surg 2020; 72:2069–2078. e4.
Barenbrock H, Feld J, Lakomek A, et al. Sex-related differences in outcome after endovascular revascularization for lower extremity artery disease: a single-centre analysis of a specialized vascular unit. Vasa 2022; 51:29–36.
Honda Y, Hirano K, Yamawaki M, et al. Atrial fibrillation is associated with femoropopliteal totally occlusive in-stent restenosis: a single-center, retrospective, observational study. J Interv Cardiol 2021; 2021:8852466.
Katsuki T, Yamaji K, Soga Y, et al. New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication. Catheter Cardiovasc Interv 2021; 98:E395–E402.
Tomoi Y, Takahara M, Soga Y, et al. Prognostic value of the CHA2DS2-VASc score after endovascular therapy for femoral popliteal artery lesions. J Atheroscler Thromb 2021; 28:1153–1160.
Hawkins BM, Kennedy KF, Giri J, et al. Preprocedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE registry. J Am Coll Cardiol 2012; 60:1617–1622.
Chang S-H, Tsai Y-J, Chou H-H, et al. Clinical predictors of long-term outcomes in patients with critical limb ischemia who have undergone endovascular therapy. Angiology 2014; 65:315–322.
Ogata T, Inoue T, Okada Y. Outcome of 312 Japanese patients with carotid endarterectomy and factors associated with cardiovascular events: a single-center study in Japan. J Stroke Cerebrovasc Dis 2014; 23:529–533.
Ralevic S, Perunicic J, Lasica R, et al. Prognostic significance of atrial fibrillation in lower limb amputee patients. Eur J Vasc Endovasc Surg 2016; 52:823–829.
Behrendt C-A, Heidemann F, Haustein K, Grundmann R, Debus E. Percutaneous endovascular treatment of infrainguinal PAOD. Gefässchirurgie 2017; 22:17–27.
Higashitani M, Uemura Y, Mizuno A, et al. Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease: short-term results of the TOMA-code registry. Circ J 2018; 82:1917–1925.
Reis P, Lopes AI, Leite D, et al. Incidence, predictors and validation of risk scores to predict postoperative mortality after noncardiac vascular surgery, a prospective cohort study. Int J Surg 2020; 73:89–93.
Perić VS, Golubović MD, Lazarević MV, et al. Predictive potential of biomarkers and risk scores for major adverse cardiac events in elderly patients undergoing major elective vascular surgery. Rev Cardiovasc Med 2021; 22:1053–1062.
Andrews N, Jenkins J, Andrews G, Walker P. Using postoperative cardiac troponin-i (cTi) levels to detect myocardial ischaemia in patients undergoing vascular surgery. Cardiovasc Surg 2001; 9:254–265.
Perzanowski C, Gandhi S, Pai RG. Incidence and predictors of atrial fibrillation after aortic repairs. Am J Cardiol 2004; 93:928–930.
Feringa HHH, Karagiannis S, Vidakovic R, et al. Comparison of the incidences of cardiac arrhythmias, myocardial ischemia, and cardiac events in patients treated with endovascular versus open surgical repair of abdominal aortic aneurysms. Am J Cardiol 2007; 100:1479–1484.
Winkel TA, Schouten O, Hoeks SE, Verhagen HJM, Bax JJ, Poldermans D. Prognosis of transient new-onset atrial fibrillation during vascular surgery. Eur J Vasc Endovasc Surg 2009; 38:683–688.
Winkel TA, Schouten O, Hoeks SE, et al. Risk factors and outcome of new-onset cardiac arrhythmias in vascular surgery patients. Am Heart J 2010; 159:1108–1115.
Alonso-Coello P, Cook D, Xu SC, et al. Predictors, prognosis, and management of new clinically important atrial fibrillation after noncardiac surgery: a prospective cohort study. Anesth Analg 2017; 125:162–169.
Golubovic M, Peric V, Stanojevic D, et al. Potential new approaches in predicting adverse cardiac events one month after major vascular surgery. Med Princ Pract 2019; 28:63–69.
Lazarević M, Golubović M, Milić D, et al. Preoperative levels of the soluble urokinase-type plasminogen activator receptor as predictor for new episodes of atrial fibrillation after vascular surgery. Vasc Endovasc Surg 2021; 55:461–466.
Valentine RJ, Rosen SF, Cigarroa JE, Jackson MR, Modrall JG, Clagett GP. The clinical course of new-onset atrial fibrillation after elective aortic operations. J Am Coll Surg 2001; 193:499–504.
Noorani A, Walsh SR, Tang TY, et al. Atrial fibrillation following elective open abdominal aortic aneurysm repair. Int J Surg 2009; 7:24–27.
Sposato LA, Suárez A, Jáuregui A, et al. Intraoperative hypotension, new onset atrial fibrillation, and adverse outcome after carotid endarterectomy. J Neurol Sci 2011; 309:5–8.
Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 2012; 164:918–924.
Kothari AN, Halandras PM, Drescher M, et al. Transient postoperative atrial fibrillation after abdominal aortic aneurysm repair increases mortality risk. J Vasc Surg 2016; 63:1240–1247.
Blanco BA, Kothari AN, Halandras PM, et al. Transient atrial fibrillation after open abdominal aortic revascularization surgery is associated with increased length of stay, mortality, and readmission rates. J Vasc Surg 2017; 66:413–422.
McAlister F, Jacka M, Graham M, et al. The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing noncardiac surgery: a VISION sub-study. J Thromb Haemost 2015; 13:1768–1775.
Cho MS, Lee CH, Kim J, et al. Clinical implications of preoperative nonvalvular atrial fibrillation with respect to postoperative cardiovascular outcomes in patients undergoing noncardiac surgery. Korean Circ J 2020; 50:148–159.
So WZ, Tan FL, Tan DJH, et al. A systematic review and meta-analysis on the impact of preexisting and new-onset atrial fibrillation on outcomes before and after liver transplantation. Digest Liver Dis 2022; 54:614–621.
Vrsalović M, Presečki AV. Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: a meta-analysis of prospective studies. Clin Cardiol 2017; 40:1231–1235.
McAlister F, Youngson E, Jacka M, Devereaux P. Investigators vascular events in noncardiac surgery patients cohort evaluation (VISION). A comparison of four risk models for the prediction of cardiovascular complications in patients with a history of atrial fibrillation undergoing noncardiac surgery. Anaesthesia 2020; 75:27–36.
Anandasundaram B, Lane D, Apostolakis S, Lip G. The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. J Thromb Haemost 2013; 11:975–987.
Boriani G, Vitolo M, Diemberger I, et al. Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc Res 2021; 117:1–21.
Vitolo M, Proietti M, Shantsila A, Boriani G, Lip GYH. Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes. Biomedicines 2021; 9:843.
Antoniou GA, Chalmers N, Georgiadis GS, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013; 57:242–253.
Boriani G, Vitolo M, Lane DA, Potpara TS, Lip GY. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. Eur J Intern Med 2021; 86:1–11.
Kolben Y, Kessler A, Puris G, et al. Management of heart failure with reduced ejection fraction: challenges in patients with atrial fibrillation, renal disease and in the elderly. Rev Cardiovasc Med 2022; 23:16.
Butt JH, Olesen JB, Havers-Borgersen E, et al. Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery. J Am Coll Cardiol 2018; 72:2027–2036.
Chebbout R, Heywood EG, Drake TM, et al. A systematic review of the incidence of and risk factors for postoperative atrial fibrillation following general surgery. Anaesthesia 2018; 73:490–498.
Halvorsen S, Mehilli J, Cassese S, et al. ESC Scientific Document Group. ESC Guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery: developed by the task force for cardiovascular assessment and management of patients undergoing noncardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC). Eur Heart J 2022; 43:3826–3924.
Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019; 16:417–436.
Boriani G, Diemberger I, Martignani C, Biffi M, Branzi A. The epidemiological burden of atrial fibrillation: a challenge for clinicians and healthcare systems. Eur Heart J 2006; 27:893–894.
Hyun J, Cho MS, Nam GB, et al. Natural course of new-onset postoperative atrial fibrillation after noncardiac surgery. J Am Heart Assoc 2021; 10:e018548.
Wang EY, Hulme OL, Khurshid S, et al. Initial precipitants and recurrence of atrial fibrillation. Circ Arrhythm Electrophysiol 2020; 13:e007716.
Boriani G, Vitolo M, Imberti JF. Atrial fibrillation postcoronary or cardiac surgery: a transient inflammation-related event or the expression of a preexisting arrhythmogenic atrial substrate? Kardiol Pol 2022; 80:877–879.
Tufano A, Lancellotti P. Atrial cardiomyopathy: pathophysiology and clinical implications. Eur J Intern Med 2022; 101:29–31.
Maesen B, Verheule S, Zeemering S, et al. Endomysial fibrosis, rather than overall connective tissue content, is the main determinant of conduction disturbances in human atrial fibrillation. Europace 2022; 24:1015–1024.
Eichenlaub M, Mueller-Edenborn B, Minners J, et al. Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation mapping for detection of atrial cardiomyopathy. Europace 2022; 24:1102–1111.
Jaakkola S, Paana T, Airaksinen J, Sipilä J, Kytö V. Association of CHA2DS2-VASc score with long-term incidence of new-onset atrial fibrillation and ischemic stroke after myocardial infarction. J Clin Med 2022; 11:7090.
Renda G, Ricci F, Patti G, et al. CHA 2 DS 2 VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation. Eur J Prev Cardiol 2019; 26:1987–1997.
Himmelreich JCL, Veelers L, Lucassen WAM, et al. Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis. Europace 2020; 22:684–694.
Hindricks G, Potpara T, Dagres N, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42:373–498.
Imberti JF, Mei DA, Vitolo M, et al. Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. Eur J Intern Med 2022; 101:1–7.
Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010; 14:iii, ix–xi, 1–193.
Simmonds M. Quantifying the risk of error when interpreting funnel plots. Syst Rev 2015; 4:1–7.

Auteurs

Vincenzo L Malavasi (VL)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Federico Muto (F)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Pietro A C M Ceresoli (PACM)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Matteo Menozzi (M)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Ilaria Righelli (I)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Luigi Gerra (L)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Marco Vitolo (M)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena.

Jacopo F Imberti (JF)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena.

Davide A Mei (DA)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Niccolò Bonini (N)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena.

Mauro Gargiulo (M)

Vascular Surgery, Department of Medical and Surgical Sciences, University of Bologna.
Vascular Surgery Unit, IRCCS University Hospital Policlinico S. Orsola, Bologna, Italy.

Giuseppe Boriani (G)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH